14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $1.91 $2.61 Thursday, 2nd May 2024 CHRS stock ended at $2.17. This is 5.34% more than the trading day before Wednesday, 1st May 2024. During the day the stock fluctuated 6.90% from a day low at $2.03 to a day high of $2.17.
90 days $1.91 $2.87
52 weeks $1.44 $8.22

Historical Coherus BioSciences prices

Date Open High Low Close Volume
May 12, 2020 $17.84 $18.27 $16.95 $16.99 1 246 537
May 11, 2020 $17.18 $17.90 $16.92 $17.68 1 086 482
May 08, 2020 $16.80 $17.41 $16.52 $17.30 1 463 990
May 07, 2020 $16.37 $17.15 $16.22 $16.66 1 046 463
May 06, 2020 $16.82 $16.82 $15.87 $16.19 609 488
May 05, 2020 $16.35 $16.84 $16.10 $16.62 1 419 994
May 04, 2020 $15.85 $16.19 $15.56 $16.02 963 296
May 01, 2020 $16.26 $16.66 $15.58 $16.03 1 654 526
Apr 30, 2020 $16.66 $17.06 $16.49 $16.60 727 837
Apr 29, 2020 $17.42 $17.45 $16.49 $16.83 1 111 493
Apr 28, 2020 $18.00 $18.19 $16.88 $16.97 1 118 626
Apr 27, 2020 $17.52 $18.22 $17.42 $17.66 1 462 975
Apr 24, 2020 $16.66 $17.45 $16.66 $17.33 1 260 561
Apr 23, 2020 $16.55 $17.17 $16.46 $16.60 1 209 620
Apr 22, 2020 $16.52 $16.67 $15.96 $16.32 1 164 679
Apr 21, 2020 $15.74 $16.84 $15.70 $16.23 2 312 562
Apr 20, 2020 $15.43 $17.12 $15.21 $16.55 3 039 716
Apr 17, 2020 $15.57 $15.64 $14.98 $15.53 2 819 484
Apr 16, 2020 $14.69 $15.07 $14.32 $15.00 3 190 318
Apr 15, 2020 $14.50 $14.81 $14.12 $14.49 5 906 217
Apr 14, 2020 $14.91 $15.17 $14.23 $14.82 5 527 376
Apr 13, 2020 $17.10 $17.10 $15.74 $15.84 649 368
Apr 09, 2020 $16.94 $17.21 $16.39 $16.70 670 925
Apr 08, 2020 $16.49 $16.56 $15.63 $16.45 722 994
Apr 07, 2020 $16.50 $16.63 $15.94 $16.12 1 456 350
Click to get the best stock tips daily for free!

About Coherus BioSciences

Coherus BioSciences Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. The company also develops Toripalimab, a novel anti-PD-1 antibody for second-line treatment of melanoma ... CHRS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT